American Journal of Lifestyle Medicine (AJLM), published bimonthly, is a professional resource for practitioners seeking to incorporate lifestyle practices into clinical medicine. AJLM focuses on:
- Recognizing and addressing the impact that lifestyle decisions and activities have on health
- Emphasizing the interaction between traditional therapies (e.g. pharmaceuticals, nutritional products, etc.) and lifestyle modalities to treat disease and achieve superior outcomes
- Highlighting and providing information about therapies that minimize the extent to which illness impacts lifestyle.
AJLM publishes a broad range of articles intended to help primary care providers and other health professionals guide their patients to lead healthier lifestyles. The journal provides commentaries and research reviews on nutrition and diet, cardiovascular disease, obesity, anxiety and depression, sleep problems, metabolic disease, and more—in a readable, immediately accessible, and usable format.
The journal is edited by Dr. James M. Rippe, a nationally renowned cardiologist and authority on health, fitness, healthy weight loss and lifestyle medicine. Author of over 42 books on health and fitness for the public and editor of leading medical textbooks in intensive care and lifestyle medicine, Dr. Rippe is the founder of Rippe Lifestyle Institute, a leading research, communication and health promotion organization. He is also the founder and director of the Rippe Health Evaluation, a series of comprehensive health evaluations conducted at the state-of-the-art medical facility in the town of Celebration, Florida.
A peer-reviewed professional resource, American Journal of Lifestyle Medicine covers topics including, but not limited to:
- Addictive disorders
- Allergies & respiratory infections
- Anxiety & depression
- Cardiovascular disease
- Coronary artery disease
- Dermatology & skin care
- Men’s health
- Metabolic Syndrome
- Nutrition & diet
- Obesity & weight management
- Pulmonary medicine
- Sleep disorders
- Sports medicine
- Women’s health
|James M. Rippe, MD||Rippe Lifestyle Institute, Shrewsbury, MA|
|Theodore J. Angelopoulos, PhD MPH||School of Health Sciences Emory & Henry College, Emory, VA|
|Elizabeth A. Grady||Rippe Lifestyle Institute, Shrewsbury, MA|
|Wayne S. Dysinger, MD, MPH||Loma Linda University, Loma Linda, CA|
|Rob Lawson, BSc, MBChB, MRCGP, FRCGP||Cockenzie House and Gardens, UK|
|John Stevens, RN, PhD, FACN||Southern Cross University, Australia|
|Henry R. Black, MD||New York University Langone Medical Center, New York, NY|
|Steven N. Blair, PED||University of South Carolina, Columbia, SC|
|Jonathan P. Bonnet||University of Florida, Gainesville, FL|
|David R. Brown, PhD||Centers for Disease Control and Prevention, Atlanta, GA|
|Joseph Ciccolo, MD||Columbia University, New York, NY|
|Ronald J. DeBellis, PharmD, FCCP||National Organization for Rare Disorders (NORD), Boston, MA|
|Colin A. Depp, PhD||University of California, San Diego, La Jolla, CA|
|J. Larry Durstine, PhD||University of South Carolina, Columbia, SC|
|Johanna Dwyer, DSC, RD, LDN||Tufts New England Medical Center, Boston, MA|
|Charles B. Eaton, MD, MS||Memorial Hospital of Rhode Island, Pawtucket, RI|
|Garry Egger, MPH, PhD||Centre for Health Promotion and Research, Australia; Southern Cross University, Australia|
|Mark D. Faries, PhD||Stephen F. Austin State University, Nacogdoches, TX|
|John P. Foreyt, PhD||Baylor College of Medicine Research Center, Houston, TX|
|Barry A. Franklin, PhD, FACSM||Beaumont Health Center, Royal Oak, MI|
|Elizabeth P. Frates, MD||Spaulding Rehabilitation Hospital, Charlestown, MA|
|Craig F. Garfield, MD, MAPP||Northwestern University, Chicago, IL|
|Cynthia Johnson Geyer, MD||Canyon Ranch, Lenox, MA|
|Regan A. R. Gurung, PhD||University of Wisconsin Green Bay, Green Bay, WI|
|George Guthrie, MD, MPH, CDE, CNS, FAAFP, FAALM||American College of Lifestyle Medicine, Chesterfield, MO|
|Gregory A. Hand, PhD, MPH||University of South Carolina, Columbia, SC|
|Craig A. Johnston, PhD||University of Houston, Houston, TX|
|David M. Joyner, MD, LLC||Andrews Institute for Orthopaedics & Sports Medicine, Gulf Breeze, FL|
|Arthur S. Leon, MS, MD||University of Minnesota, Minneapolis, MN|
|Josh Lowndes, MA||Rippe Lifestyle Institute, Celebration, FL|
|JoAnn E. Manson, MD, DrPH||Brigham and Women's Hospital, Harvard Medical School, Boston, MA|
|Bess H. Marcus, PhD||University of California, San Diego, La Jolla, CA|
|Jeffrey I. Mechanick, MD||The Mount Sinai Hospital, New York, NY|
|Jesse Stabile Morrell, PhD||University of New Hampshire, Durham, NH|
|Roland W. Moskowitz, MD||Case Western Reserve University, Beachwood, OH|
|Michael O'Donnell, PhD, MBA, MPH||American Journal of Health Promotion, Cleveland, OH|
|Russ Pate, PhD||University of South Carolina, Columbia, SC|
|James O. Prochaska, PhD||University of Rhode Island, Kingston, RI|
|William F. Rippe, MD||Heartland Clinic, St. Joseph, MO|
|Thomas Rowland, MD||Baystate Medical Center, Springfield, MA|
|Nancy Rudner Lugo, DrPH, RN||Health Action, Maitland, FL|
|Veronica Schimp, DO||MD Anderson Cancer Center Orlando, Orlando, FL|
|Richard Simpson, PhD||University of Houston, Houston, TX|
|David Sleet, PhD, FAAHB||National Center for Injury Prevention and Control, Atlanta, GA|
|Gerald Smith, PhD, PT||University of Central Florida, Orlando, FL|
|Alan C. Utter, PhD, MPH, FACSM||Appalachian State University, Boone, NC|
|Nicole White, PharmD||Creighton University, Omaha, NE|
Editorial Purpose and Policies
The American Journal of Lifestyle Medicine (AJLM) will serve as a forum for health care professionals to share evidence or experience-based information on how daily lifestyle practices and habits impact both short and long-term health and quality of life. The primary audiences for AJLM are primary care physicians and family practitioners. Authors should focus on the needs and interests of these individuals with particular emphasis on clinical relevance to any data cited or recommendations made.
The Journal welcomes manuscripts in the following areas of interest:
• Editorials: 2–3 pages (1200 –1800 words)
• State of the Art Reviews: 8 – 12 pages (4800 –7200 words)
• Original Research Articles: Original, in-depth, clinical or basic science investigations that aim to change clinical practice or the understanding of a disease process. Article types include, but are not limited to, clinical trials, before-and-after studies, cohort studies, case-control studies, cross-sectional surveys, and diagnostic test assessments. 8 – 12 pages (4800 –7200 words)
Manuscripts will be critically reviewed by an editor with appropriate independent referees from the Editorial Board and other expert sources. Manuscripts are considered with the stipulation that they are submitted solely to AJLM and that no part of the submission has previously appeared elsewhere. Where questions exist, authors should submit copies of material that has appeared elsewhere. Statements and opinions expressed in the articles and communications appearing in the journal are those of the author(s) and not necessarily those of the editors and publisher. The editors and publisher disclaim any responsibility or liability for such material. Neither the editors nor the publisher guarantee, warrant, or endorse any product or service advertised in this publication, nor do they guarantee any claim made by the manufacturer of such product or service.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.
The SAGE Track site for AJLM can be found here: https://mc.manuscriptcentral.com/ajlm
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section.
Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Individuals who provided writing assistance, e.g. from a specialist communciations company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.
It is not necessary to disclose use of language polishing services.
AJLM requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Declaration of Conflicting Interests
It is the policy of AJLM to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations here.
Research ethics and patient consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
AJLM conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart as a cited figure, and a completed CONSORT checklist as a supplementary file.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Contributor’s publishing agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
Submission of Manuscripts
Manuscripts must be prepared and submitted in the manner described in the American Medical Association Manual of Style. Send manuscripts through SageTrack at:
Transfer of copyright to SAGE Publications is a condition of publication (authors will receive a copyright transfer form prior to publication). Any questions should be directed to Elizabeth Grady, Managing Editor, at firstname.lastname@example.org or (508) 756-1306.
The manuscript is typed on white paper, 8½ × 11 in. (22 × 28 cm), with margins of at least 2.5 cm (1 in.) at top, bottom, and both sides.
Use double spacing.
Arrange the manuscript with the following sections and begin each section on a separate page: (1) title page, (2) abstract, (3) key words, (4) text, (5) acknowledgments, (6) references, (7) glossary (if needed), (8) tables (each table on a separate page), (9) figures, and (10) legends.
All pages should be numbered consecutively, beginning with the title page, and the first author’s name and the page number should be included in the upper right corner of each page.
Abbreviated terms are spelled out at first use and followed with the abbreviation in parentheses. Avoid overuse of contrived abbreviations.
Written permission to use nonoriginal material (quotations exceeding 100 words, any table or illustration) from both author and publisher of the original is included, and the source is credited in the manuscript. No article will be accepted as a submission to AJLM without all required permissions.
Title page. Include (1) the full title of the paper — short, clear, and specific; (2) authors’ full names; (3) degrees and institutional affiliation of all authors; (4) name, address (including zip code), e-mail address, and phone number of all contributing authors; and (5) a running title of 3 or 4 words. Indicate the author to whom communications should go to regarding the manuscript and reprint requests.
Abstract. Provide an article summary of 200 words or less.
Key words. Include 4 to 5 key words.
Grant and other acknowledgments. Specify support of any work discussed, by a grant or otherwise, as well as the meeting, if any, at which the paper was presented (including place and date).
Double-space references throughout, number them in the sequence in which they appear in the text, and identify them in text by superscript Arabic numerals. Accuracy and completeness of references are the author’s responsibility. Format references per the American Medical Association Manual of Style. If there are more than 6 authors, the first 3 authors are used followed by “et al” including names and initials of all authors. Index Medicus abbreviations are used for journal titles, volume, inclusive page numbers, and year:
Mazze RI, Cousins MJ, Kosek JC. Strain differences in metabolism and susceptibility to the nephrotoxic effects of methoxyflurane in rats. J Pharmacol Exp Ther. 1973;184:481-488.
Baston HC. An Introduction to Statistics in the Medical Services. Minneapolis, Minn: Burgess; 1956:110-114.
Cohen PJ, Marshall BE. Effects of halothane on respiratory control in rat liver mitochondria. In: Fink BR, ed. Toxicity of Anesthetics. Baltimore, Md: Williams and Wilkins; 1968:24-36.
Tables. Double space on pages separate from the text. Tables should not duplicate material text or illustrations.
Legends. Credit for any previously published illustration must be given in the corresponding legend. All symbols should be explained in the legend.
Figure and Artwork Submission
Artwork includes charts and graphs, maps, photographs, line art, and tables with 17 or more columns.
Electronic art. Acceptable file formats include the following: TIFF, EPS, JPEG, and PDF. Microsoft application files are acceptable for vector art (line art).
Scanned images. Line art (black and white) images should be scanned as a bitmap at 900ppi. Photos should be scanned as grayscale or CMYK at 300ppi.
Advertising and Reprints
Current advertising rates and specifications maybe obtained by contacting the advertising coordinator at (805) 410-7772 or by sending an e-mail to email@example.com. Reprints may be ordered by using the special reprint order form that will accompany author proofs. If you need another copy of this order form please call (805) 410-7763 or e-mail firstname.lastname@example.org. Acceptance of advertising in this journal in no way implies endorsement of the advertised product or service by SAGE or the journal’s affiliated society(ies). No endorsement is intended or implied. SAGE reserves the right to reject any advertising it deems as inappropriate for this journal.
If you are interested in publishing a peer-reviewed supplement or sponsoring a special mailing list, please contact Barbara Eisenberg at (805) 410-7763, email@example.com.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate.
- Title page
- Key words
- Glossary (if needed)
- Tables (each table on a separate page)